Tau Therapeutics Adds $3M in Equity Financing

Tau Therapeutics, an oncology company developing “T-type calcium channel inhibitors” for the treatment of solid tumors, has raised $3 million in financing. The company is based in Charlottesville, Va. Details of the round were not disclosed.

North AmericaUSBriefs